01 — The Text
What.
- Expands federal grants to equip first responders with rapid test strips that detect fentanyl, xylazine, and other synthetic opioids.
- Requires HHS to publish standards and guidance helping manufacturers develop and get these test strips authorized.
- Mandates HHS study on whether test strip availability reduces overdose deaths and increases treatment enrollment.
02 — The Stakes
So what?
- First responders and overdose prevention programs gain tools to identify dangerous drug combinations before they kill someone.
- People struggling with addiction benefit from faster intervention; communities get data on whether this approach actually saves lives.
- Drug manufacturers get clearer rules for bringing detection products to market; no apparent winners or losers—broad public health play.
03 — The Path
Now what?
- Passed committee 48-0 in July 2026; heading to full House floor for a vote.
- If passed by House, goes to Senate; strong bipartisan support suggests smooth path forward.
- Contact your House representative now to urge a floor vote if you support expanding overdose prevention tools.
Legislative History
Actions.
- Jul 21, 2026 — Committee Consideration and Mark-up Session Held
- Jul 21, 2026 — Ordered to be Reported by the Yeas and Nays: 48 - 0.
- Jul 20, 2026 — Committee Consideration and Mark-up Session Held
- Jun 25, 2026 — Forwarded by Subcommittee to Full Committee by Voice Vote.
- Jun 25, 2026 — Subcommittee Consideration and Mark-up Session Held
- Feb 25, 2025 — Referred to the Subcommittee on Health.
- Feb 25, 2025 — Referred to the House Committee on Energy and Commerce.
- Feb 25, 2025 — Introduced in House